| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0045 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |